WASHINGTON (Reuters) – The Appropriations Committee of the House of Representatives made clear on Tuesday that automatic spending cuts will be a recurring nightmare for Washington as it passed a measure to sharply reduce funding for government agencies and programs … Continue reading
WASHINGTON (Reuters) – The Senate Judiciary Committee on Tuesday approved legislation that would bring about the biggest changes in U.S. immigration policy in a generation, setting up a spirited debate in the full Senate next month.
WASHINGTON (Reuters) – Americans at high risk for heart problems who have been told for years to sharply cut salt from their diet may not actually benefit from ultra-low sodium diets and could even face some harm, an independent panel … Continue reading
NEWTOWN, Connecticut (Reuters) – A special task force of elected town officials on Friday recommended tearing down Connecticut’s Sandy Hook Elementary School, where 20 children and six adults were shot to death in December, and rebuilding it on the site … Continue reading
WASHINGTON, April 23 (Reuters) – Senate Commerce Committee leaders on Tuesday pressed the Obama administration for more information on how its plan to furlough air traffic controllers and close…
Leading global financial officials on Saturday pledged faster action to boost growth and job creation in the developed world, amid deepening concern that advanced nations have become too reliant on cheap money and loose central bank policies to sustain their … Continue reading
* Panel votes Breo effective in treating airflow obstruction
(Reuters) – An advisory panel to the U.S. Food and Drug Administration has recommended that the agency approve an experimental treatment for smoking-related lung damage made by Britain’s GlaxoSmithKline Plc and Theravance Inc.
(Reuters) – A federal health advisory panel in June will reconsider safety data on GlaxoSmithKline Plc’s Avandia diabetes drug, although the British drugmaker on Friday said it has not sought permission to make the nearly discontinued drug widely available again … Continue reading
(Reuters) – Pharmaceutical company Merck & Co Inc said on Tuesday an independent monitoring board had allowed it to continue with a large trial assessing the safety and effectiveness of its Vytorin cholesterol treatment.